How can Real-World Data (RWD) and Real-World Evidence (RWE) better support the HTA evaluation of medical devices?

This was the central theme of a dedicated panel discussion moderated by GREG consortium members at ISPOR Europe, examinating both current bottlenecks and future opportunities in Health Technology Assessment (HTA).

The conversation focused on exploring three questions:

  • What makes RWD fit for purpose?
  • How can it support decisions across a device’s lifecycle?
  • And what needs to change to strengthen the RWD/ RWE ecosystem?

Current bottlenecks: tackling data gaps and device identification

A recurring theme throughout the session was that the primary hurdle today is rarely a lack of analytical methods: it is whether the available data actually match the question being asked. In routine clinical datasets, an intervention is often recorded without specifying the exact medical device used. Furthermore, connecting short-term registry data with long-term patient outcomes remains complex, particularly as data completeness tends to drop over time. Overcoming these limitations means establishing clear data-quality and relevance criteria working hand-in-hand with key stakeholders such as clinical experts.

New opportunities: AI-supported devices and digital health technologies

Despite these challenges, the panel emphasized the transformative value of RWD when device assessment is approached with an open mind. Real-world data offers valuable insights on how technologies are integrated into everyday care pathways. This perspective is becoming indispensable for AI-supported devices, digital health technologies, and platforms, where relying exclusively on conventional randomised controlled trials is proving increasingly difficult.

A Collective Effort at the heart of GREG

Closing the gap between potential and practice will take more than methods alone. It requires better harmonisation across datasets and a close collaboration between academia, industry, clinicians, and HTA bodies to build practical guidance and training. Thankfully GREG is here to work on these topics!

More news

  • November 13th, 2026

    Real-World Evidence for Medical Devices in HTA: Insights from ISPOR Europe 2026

    Vienna, 9th - 12th November 2026

  • November 12th, 2026

    Meet the Work Package – WP9

    WP9 - Project Management and Coordination

  • November 5th, 2026

    Meet the Work Package – WP7

    WP7 - Engagement of Patients and Patient Communities

  • October 28th, 2026

    GREG at IHI Forum 2026

    Brussels, 20 October - 21 October 2026

  • October 2nd, 2026

    Meet the Work Package – WP5

    WP5 - RWE for the Development and Evaluation of Medical Devices and Drug-Device Combinations

  • September 8th, 2026

    GREG inspires at ISPE 2026

    Milan, 29 August - 02 September 2026

  • July 15th, 2026

    Meet the Work Package – WP2

    WP2 – RWE for Regulatory Decision-Making

  • July 8th, 2026

    Welcome back for the 2nd GREG Newsletter

    Issue 2 - June 2026

  • July 8th, 2026

    Meet the Work Package – WP3

    WP3 – RWE for Health Technology Assessment (HTA)

  • June 17th, 2026

    Meet the Work Package – WP1

    WP1 - Evidence-Based Practical Guidance for the Use of Real-World Data in Evidence Generation for HTA and Regulatory Decision-Making